New blood test to guide antibiotic use in newborns
Part of Genetic & congenital, Infections clinical trials.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be in the neonatal intensive care unit (NICU).
- Your baby must be at least 7 days old.
- Your baby must weigh at least 500 grams (about 1.1 pounds).
- Your baby must have signs of a possible late-onset infection (like fever, breathing problems, or skin changes).
- Your baby must not be on antibiotics for a confirmed infection right now or in the past 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a blood test (presepsin) can help doctors safely stop antibiotics earlier in preterm babies at moderate risk of infection. The goal is to reduce unnecessary antibiotic use.
This study is testing a new blood test (called presepsin) to see if it can help doctors quickly diagnose sepsis (a serious infection) in newborns. If your baby has signs of infection, this test might help find the cause sooner.
This study looks at how blood markers like lactate and complete blood count (CBC) can help spot infection in newborns up to 28 days old. It may lead to faster, more accurate diagnosis for babies with possible sepsis.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This trial is testing ways to make the best treatment decisions for newborns who may have an early infection (sepsis). It focuses on babies born at 34 weeks or later and within their first three days of life.
This study looks at germs that cause infections in newborns and which antibiotics work best against them. It aims to help doctors choose the right treatment for babies in the intensive care unit.
Hear when a new Neonatal Late Onset Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.